Parent-Proxy EQ-5D Ratings of Children with Attention-Deficit Hyperactivity Disorder in the US and the UK

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.23, Iss.8, 2005-01, pp. : 777-790

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Atomoxetine in Attention-Deficit Hyperactivity Disorder in Children and Adolescents†

By Garnock-Jones Karly P. Keating Gillian M.

CNS Drugs, Vol. 24, Iss. 1, 2010-01 ,pp. : 85-88

Adis International

Access to resources Recommend Favorite

Lisdexamfetamine is a promising treatment for children with attention-deficit hyperactivity disorder

Inpharma, Vol. 1, Iss. 1543, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Atomoxetine: A Review of its Use in Attention-Deficit Hyperactivity Disorder in Children and Adolescents

By Garnock-Jones Karly P. Keating Gillian M.

Pediatric Drugs, Vol. 11, Iss. 3, 2009-05 ,pp. : 203-226

Adis International

Access to resources Recommend Favorite

Methylphenidate Transdermal System: In Attention-Deficit Hyperactivity Disorder in Children

By Anderson Vanessa R. Scott Lesley J.

Drugs, Vol. 66, Iss. 8, 2006-01 ,pp. : 1117-1126

Adis International

Access to resources Recommend Favorite

Methylphenidate Transdermal System in Attention-Deficit Hyperactivity Disorder in Children: Profile Report

By Anderson Vanessa R. Scott Lesley J.

American Journal of Drug Delivery, Vol. 4, Iss. 3, 2006-01 ,pp. : 189-191

Adis International

Access to resources Recommend Favorite